UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Completed
Unique ID issued by UMIN UMIN000033630
Receipt No. R000038345
Official scientific title of the study Hypercalcemia and Acute Kidney Injury Induced by Eldecalcitol in Patients with Osteoporosis
Date of disclosure of the study information 2018/08/03
Last modified on 2018/08/03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Hypercalcemia and Acute Kidney Injury Induced by Eldecalcitol in Patients with Osteoporosis
Title of the study (Brief title) Hypercalcemia and Acute Kidney Injury Induced by Eldecalcitol in Patients with Osteoporosis
Region
Japan

Condition
Condition Hypercalcemia and Acute Kidney Injury
Classification by specialty
Nephrology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 The purpose of our study was to examine the clinical course and characteristics of patients with hypercalcemia and AKI induced by ELD at the time of admission at a single facility.
Basic objectives2 Others
Basic objectives -Others none
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Creatinine, calcium
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
100 years-old >
Gender Male and Female
Key inclusion criteria none
Key exclusion criteria none
Target sample size 32

Research contact person
Name of lead principal investigator Oka Hideaki
Organization Matsuyama Red Cross Hospital
Division name Kidney Center
Address 1 Bunkyo-cho, Matsuyama-shi, Ehime
TEL 089-924-1111
Email okanokao@matsuyama.jrc.or.jp

Public contact
Name of contact person Oka Hideaki
Organization Matsuyama Red Cross Hospital
Division name Kidney Center
Address 1 Bunkyo-cho, Matsuyama-shi, Ehime
TEL 089-924-1111
Homepage URL
Email okanokao@matsuyama.jrc.or.jp

Sponsor
Institute Matsuyama Red Cross Hospital
Institute
Department

Funding Source
Organization Matsuyama Red Cross Hospital
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2018 Year 08 Month 03 Day

Progress
Recruitment status Completed
Date of protocol fixation
2013 Year 04 Month 01 Day
Anticipated trial start date
2018 Year 09 Month 30 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information none

Management information
Registered date
2018 Year 08 Month 03 Day
Last modified on
2018 Year 08 Month 03 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038345

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.